Otsuka (OTCMKTS:OTSKY) Releases Earnings Results, Beats Expectations By $0.19 EPS

Otsuka (OTCMKTS:OTSKY) announced its earnings results on Friday. The company reported $0.70 EPS for the quarter, topping the consensus estimate of $0.51 by $0.19, Zacks reports. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka updated its FY 2026 guidance to 2.119-2.119 EPS.

Otsuka Stock Performance

OTSKY stock traded down $1.42 during mid-day trading on Friday, hitting $34.41. 50,465 shares of the company were exchanged, compared to its average volume of 39,967. Otsuka has a 1-year low of $23.67 and a 1-year high of $37.52. The stock has a market capitalization of $36.96 billion and a PE ratio of 14.52. The business has a 50 day simple moving average of $34.19 and a 200-day simple moving average of $33.51. The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.